Dow May Exit $20B Aramco JV; Losses Hit $793M

For equity and credit investors, the Sadara stake is a balance-sheet cleanup question: Dow's 35 percent interest sits inside a $20 billion venture but carried a negative $793 million investment balance as of June 30, 2026. The potential exit would not only derisk earnings from Middle East supply-chain disruption, but could force a write-down that changes near-term profitability metrics.

Dow is weighing an exit from its $20 billion chemicals partnership with Saudi Aramco, according to a Bloomberg News report citing people familiar with the matter. The U.S. chemical giant's 35 percent stake in Sadara Chemical Co is the focus of the discussions, with Aramco identified as a potential buyer, although other strategic and financial investors could also bid. Neither company has confirmed the talks: Dow did not immediately respond to a request for comment, and Aramco declined to comment. If completed, the divestiture would mark one of the most significant portfolio restructurings in the global petrochemical industry during the current downcycle.

“

For equity and credit investors, the Sadara stake is a balance-sheet cleanup question: Dow's 35 percent interest sits inside a $20 billion venture but carried a negative $793 million investment balance as of June 30, 2026.

Sadara Chemical operates a complex in Jubail, Saudi Arabia, with annual production capacity of more than three million metric tons of chemicals and plastics. The joint venture has been destabilized by the Middle East conflict, specifically the U.S.-Israeli war on Iran, which has disrupted oil and petrochemical flows, constrained supply chains, and increased transportation and operating costs. Dow said in July that the conflict had directly affected its regional joint ventures, and production at Sadara was temporarily halted earlier in 2026 because of supply-chain disruptions. Those operational shocks compound an already weak chemicals market defined by stagnant demand, higher production costs in Europe, evolving regulatory requirements, and persistent global oversupply.

The financial strain is visible on Dow's balance sheet. As of June 30, 2026, Dow held a negative investment balance of $793 million in Sadara Chemical Co, and it suspended recognition of losses from the joint venture during the first quarter of 2026. A negative investment balance typically signals that accumulated equity-method losses have exceeded the carrying value of the investment, leaving the parent with potential future obligations rather than accounting value. The suspension of loss recognition suggests the venture has stopped contributing positively to Dow's reported earnings and is being managed as a non-core or impaired asset. This accounting treatment strengthens the logic behind a sale: the asset is no longer providing book value to Dow and is instead associated with a $793 million negative position.

A potential exit fits a broader pattern of portfolio rationalization at Dow. The company reviewed its European assets in 2024 and has been evaluating non-core holdings across its global portfolio. In January 2026, Dow announced plans to cut 13 percent of its workforce as part of an effort to improve profitability through a lower cost base and sharper asset focus. Exiting Sadara would remove a loss-making and geopolitically exposed operation from the portfolio, freeing management attention and capital for businesses with stronger cash generation. For Aramco, an exit by Dow offers an opportunity to consolidate ownership of Sadara, possibly at a favorable valuation during the industry downturn, and to integrate the Jubail complex more fully into its downstream chemicals strategy.